The global Galileo Tactile Stimulator market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estim…Read More>>
The global Surgical Skin Grafting Dermatome market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while…Read More>>
The global Anal Sphincter Retractor market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimat…Read More>>
The global Blood Bag Sealing Machine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estima…Read More>>
The global Centrifuge Adjustable Test Tube market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while …Read More>>
The global Catecholamine Hormones market was valued at US$ 4218.7 million in 2022 and is projected to reach US$ 6275.7 million by 2029, at a CAGR of 5.8% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considere…Read More>>
The global Humira Biosimilar market was valued at US$ 433.2 million in 2022 and is projected to reach US$ 955.4 million by 2029, at a CAGR of 12.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered whil…Read More>>
The global Adalimumab Monoclonal Antibody Biosimilar market was valued at US$ 433.2 million in 2022 and is projected to reach US$ 955.4 million by 2029, at a CAGR of 12.0% during the forecast period. The influence of COVID-19 and the Russia-Ukraine …Read More>>
The global Adalimumab (Humira) and Biosimilar market was valued at US$ 23070 million in 2022 and is projected to reach US$ 16210 million by 2029, at a CAGR of -4.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War wer…Read More>>
The global Avastin Biosimilar market was valued at US$ 1379.8 million in 2022 and is projected to reach US$ 484.9 million by 2029, at a CAGR of -13.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered w…Read More>>
